Every person in a study of nearly 100,000 participants carried at least one genetic variant that can affect the way the body processes medication, researchers reported, highlighting the potential reach of pharmacogenomics in everyday prescribing.
The findings, published in Science Translational Medicine, also showed that roughly one in four people in the study had received at least one medication known to interact with genetic differences. The results suggest that a patient’s genetic makeup may be an important consideration when doctors evaluate whether a drug is likely to work effectively or cause harmful side effects.
Genetic differences were widespread
Researchers examined information from more than 98,000 people enrolled in a National Institutes of Health research initiative focused on how lifestyle, environmental exposures and genetics influence health. The team looked for 16 genetic variants that previous research had linked to either the effectiveness or toxicity of medications.
All participants had at least one of the variants examined. The median number was nine variants per person, meaning half of the participants had nine or fewer and half had nine or more. The researchers then compared those findings with participants’ medical records to determine how often people had been prescribed medications affected by those genetic differences.
| Study finding | Reported result |
|---|---|
| Participants analyzed | More than 98,000 |
| Participants with at least one relevant variant | 100% |
| Median number of variants per participant | 9 |
| Participants prescribed an affected medication | 24% |
Implications for prescribing
The medications most frequently identified in the records included ondansetron, which is used to prevent nausea; ibuprofen, an anti-inflammatory medicine; and omeprazole and pantoprazole, both used to reduce stomach acid. The source material did not identify the specific genetic effects associated with each drug, but it placed the medications among those whose activity can be influenced by inherited differences.
Philip Empey, associate director for pharmacogenomics at the University of Pittsburgh’s Institute for Precision Medicine and the study’s senior researcher, said people often experience medicines that do not work as expected or produce side effects. He cautioned that genetics is only one factor shaping a patient’s response, while saying the study points to a role for more individualized prescribing.
“While many things impact how a patient responds to medication, our research tells us that genetics could be a factor for a large proportion of patients and it points to the value of precision medicine in prescribing,” Empey said.
The researchers said the findings support genetic testing for patients who are prescribed any of more than 300 medications known to be affected by genetic factors. Such testing, known as pharmacogenomic testing, is intended to provide information about how a person may process a drug before or during treatment.
What the findings do and do not show
The study does not establish that every medication will cause problems for every person with one of the variants. Instead, it shows that the genetic factors examined were common in the study population and that a substantial share of participants had been prescribed a drug recognized as genetically influenced. The researchers’ analysis connected genetic data with medical records; it did not mean that genetics alone determined whether a treatment succeeded or failed.
For patients, the findings underscore the importance of discussing medication history, side effects and treatment concerns with health professionals. They also point to a broader challenge for precision medicine: translating genetic information into prescribing decisions for the many drugs that may be affected by inherited variation, while accounting for the other factors that influence how medicines work.
- Every participant carried at least one of the 16 variants assessed.
- Twenty-four percent had received at least one medication known to interact with those genetic factors.
- The researchers identified more than 300 drugs for which genetic testing may be relevant.